U.S. Food and Drug Administration (FDA): Coronavirus (COVID-19) and Medical Devices

Coronavirus (COVID-19) and medical devices in healthcare refer to the use of medical devices in the diagnosis, treatment, and management of COVID-19, as well as the potential impacts of COVID-19 on the availability and use of medical devices.

Medical devices used in the diagnosis and treatment of COVID-19 may include respiratory support devices, such as ventilators and oxygen concentrators, as well as diagnostic tests, such as PCR tests and antibody tests.

The use of medical devices in the management of COVID-19 may also include the use of telemedicine technologies, such as remote monitoring devices and video conferencing tools, to enable healthcare providers to remotely monitor and treat patients with COVID-19.

COVID-19 may also impact the availability and use of medical devices in healthcare in a variety of ways. For example, the demand for certain medical devices, such as respiratory support devices, may increase significantly during the pandemic, leading to shortages and challenges in the supply chain. COVID-19 may also disrupt the manufacturing and distribution of medical devices, or limit the ability of healthcare providers to use certain devices due to infection control measures.

Overall, the use of medical devices in the diagnosis, treatment, and management of COVID-19 is an important aspect of the response to the pandemic, and the impacts of COVID-19 on the availability and use of medical devices in healthcare is a key concern for healthcare providers and stakeholders.